Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-10 | 80.0 | 65 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-10 | 80.5 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-10 | 84.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-10 | 74.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-10 | 94.0 | 70 | |
RA2159 | 3 | IL-10 | 75.0 | 67 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-10 | 78.0 | 53 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-10 | 63.5 | 42 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-10 | 71.0 | 62 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-10 | 86.5 | 56 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-10 | 74.0 | 50 | ||||
RA2159 | 3 | IL-10 | 66.0 | 58 | |||||||
N2586 | 3 | IL-10 | 84.0 | 52 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL-10 | 77.0 | 50 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-10 | 91.0 | 59 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-10 | 82.5 | 42 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL-10 | 74.0 | 46 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-10 | 77.0 | 55 | ||||
N2586 | 3 | IL-10 | 104.0 | 42 | |||||||
RA2159 | Visfatin | 1 | ng/mL | 3 | IL-10 | 60.5 | 50 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | IL-10 | 62.5 | 48 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-10 | 85.5 | 50 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-10 | 49.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-10 | 63.5 | 46 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | IL-10 | 69.0 | 65 |